Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
105M
-
Shares change
-
-2.43M
-
Total reported value, excl. options
-
$696M
-
Value change
-
-$17.9M
-
Put/Call ratio
-
2.12
-
Number of buys
-
40
-
Number of sells
-
-54
-
Price
-
$6.64
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q4 2018
138 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2018.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 105M shares
of 363M outstanding shares and own 28.86% of the company stock.
Largest 10 shareholders include Artal Group S.A. (60.2M shares), FMR LLC (14.7M shares), BlackRock Inc. (4.36M shares), Ulys, L.L.C. (4.32M shares), Vanguard Group Inc (2.99M shares), UBS ASSET MANAGEMENT AMERICAS INC (2.94M shares), NEA Management Company, LLC (2.38M shares), STATE STREET CORP (1.85M shares), Clearbridge Investments, LLC (1.25M shares), and SECTOR GAMMA AS (863K shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.